Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M291,110Revenue $M71,312Net Margin (%)19.4Z-Score5.3
Enterprise Value $M276,608EPS $4.8Operating Margin %25.8F-Score7
P/E(ttm))19.0Cash Flow Per Share $6.2Pre-tax Margin (%)21.7Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %3.1Quick Ratio2.1Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %-0.9Current Ratio2.5Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %7.6ROA % (ttm)10.4Higher Current Ratio y-yY
Dividend Yield %2.6Insider Buy (3m)0ROE % (ttm)18.7Less Shares Outstanding y-yY
Payout Ratio %50.0Shares Outstanding M2,829ROI % (ttm)15.4Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

JNJ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
JNJ James Barrow 2014-06-3017,065,2300.62.4+0.66%
JNJ Jean-Marie Eveillard 2014-06-301,623,4820.060.41+0.37%
JNJ Ruane Cunniff 2014-06-3076,01200.04+0.29%
JNJ Yacktman Fund 2014-06-304,050,0000.143.6
JNJ Tom Gayner 2014-06-30574,2000.021.7
JNJ Richard Perry 2014-06-30342,2770.010.99
JNJ Warren Buffett 2014-06-30327,1000.010.03
JNJ Prem Watsa 2014-06-3084,70000.61
JNJ Dodge & Cox 2014-06-3038,62500
JNJ Michael Price 2014-06-3035,00000.45
JNJ PRIMECAP Management 2014-06-3012,242,4200.431.4-0.48%
JNJ Tweedy Browne 2014-06-304,196,2240.159.4-1.71%
JNJ Donald Yacktman 2014-06-309,045,9020.323.8-5.5%
JNJ Mario Gabelli 2014-06-30373,1860.010.2-5.54%
JNJ Yacktman Focused Fund 2014-06-303,300,0000.123.5-13.16%
JNJ John Hussman 2014-06-301,32500.01-50%
JNJ George Soros 2014-06-3050,00000.04-51.22%
JNJ Ray Dalio 2014-06-3065,89300.05-74.94%
JNJ Joel Greenblatt 2014-06-30000Sold Out
JNJ Meridian Funds 2013-06-307,88500.03
Premium Most recent portfolio changes are included for Premium Members only!

JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Caruso Dominic JVP, Finance; CFO 2014-08-21Sell30,000$104.3-1.03view
COSGROVE STEPHEN JCorporate Controller 2014-05-05Sell22,000$100.053.18view
Fasolo PeterVP, Global Human Resources 2014-03-14Sell6,824$93.1510.82view
COSGROVE STEPHEN JCorporate Controller 2013-08-14Sell17,200$91.3912.96view
Ullmann Michael HVP, General Counsel 2013-08-05Sell16,140$93.6810.19view
Stoffels PaulusChief Scientific Officer 2013-07-25Sell45,440$92.411.72view
Caruso Dominic JVP, Finance; CFO 2013-07-18Sell30,000$90.3114.31view
CULLEN JAMESDirector 2013-05-07Sell4,929$85.420.88view
LINDQUIST SUSAN LDirector 2012-12-07Sell7,600$70.0247.43view
CULLEN JAMESDirector 2012-11-12Sell13,900$69.748.11view

Press Releases about JNJ :

    Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs Aug 25 2014 
    The Most Important Financial Statement When Selecting Dividend Growth Stocks Aug 21 2014 
    A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio Aug 15 2014 
    A Strong Candidate for Investor´s Portfolios Aug 12 2014 
    5 Dividend Stocks Delivering The Secret To Successful Investing Aug 06 2014 
    5 Dividend Stocks Delivering The Secret To Successful Investing Aug 05 2014 
    Why Procter & Gamble Surged Higher On Friday? Aug 03 2014 
    Outlook for August 2014 Aug 01 2014 
    Limiting Risk: A Little Exposure To High Yield Goes A Long Way Jul 29 2014 
    What’s the Right PE Ratio? Jul 29 2014 

    More From Other Websites
    The Longer Term View on Johnson & Johnson Aug 25 2014
    Vivus acquires patent rights to Qsymia ingredient Aug 25 2014
    5 P&G executives in position to become CEO Aug 23 2014
    Omnicom Offers Steady Profit Growth, Rising Dividend Aug 22 2014
    Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod Aug 22 2014
    Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf Aug 22 2014
    Gilead Sciences: Don't You Forget About Me Aug 22 2014
    Apple Stock Held By Institutional Investors Rises Aug 21 2014
    FDA Grants New Indication For Pfizer, Bristol-Myers Squibb Drug Aug 21 2014
    Illumina Partners With Big Pharma To Create New Genetic Tests For Cancer Aug 21 2014
    Allergan approaches Salix to fight Valeant bid Aug 19 2014
    Robert Wood Johnson's New Industry Made Surgery Safer Aug 14 2014
    [video] Global risk playbook Aug 12 2014
    Intercept Pharma Soars On Liver-Disease Drug Data Aug 12 2014
    Entia Biosciences' Supplements Could Prevent Dementia Aug 12 2014
    JOHNSON & JOHNSON Financials Aug 08 2014
    Medivation Cancer Drug Fuels Beat, Swings To Profit Aug 08 2014
    [video] Inside Johnson & Johnson (08/05) Aug 08 2014
    3 Companies That Should Benefit From The New Initiative In Africa Aug 07 2014
    Ebola Has Landed Aug 05 2014

    Add Notes, Comments or Ask Questions

    User Comments

    ReplyGurufocus - 10 months ago
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial